Search
for
Sort by
Research 151–180 of 1000+
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- The Role of Tofacitinib in the Management of Alopecia Totalis
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- The Role of Janus Kinase Inhibitors in Dermatology
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis